Pharmaceutical Preparations · MA · CIK 1526119
Develops and commercializes medicines for RAS/MAPK pathway-driven cancers, including AVMAPKI FAKZYNJA CO-PACK
Comparable business profile · signals at a glance
In the 90 days to Feb 4, 2026: 6 sold $563K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 4, 2026 | Paterson DanPresident and CEO | Sell | 970 | $6.69 | $6K |
| Jan 12, 2026 | Paterson DanPresident and CEO | Sell | 10,321 | $7.16 | $74K |
| Jan 12, 2026 | Calkins DanielChief Financial Officer | Sell | 5,039 | $7.16 | $36K |
| Dec 24, 2025 | Calkins DanielChief Financial Officer | Sell | 80 | $7.86 | $629 |
| Dec 16, 2025 | Stuglik Brian MDirector | Sell | 592 | $9.14 | $5K |
| Dec 16, 2025 | Paterson DanPresident and CEO | Sell | 393 | $9.14 | $4K |
| Dec 16, 2025 | Gagnon Robert E.Director | Sell | 283 | $9.14 | $3K |
| Dec 11, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Dec 10, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.07 | $20K |
| Dec 9, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.25 | $21K |
| Dec 8, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.50 | $21K |
| Dec 5, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.61 | $21K |
| Dec 4, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Dec 3, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Dec 2, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.32 | $21K |
| Dec 1, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.39 | $21K |
| Nov 28, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.79 | $22K |
| Nov 26, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.32 | $21K |
| Nov 25, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Nov 24, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.